| Name | Title | Contact Details |
|---|
Mpathy Medical is a Raynham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AlphaVax is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care. Its FDA-cleared titration software and proprietary algorithms power the only solution capable of delivering personalized diabetes treatment recommendations across the continuum of care, from hospital to home. With ongoing support from its team of doctors, nurses and technologists headquartered outside of Boston, Glytec improves outcomes and controls costs for the large population of patients requiring insulin treatment – including those with and without a diagnosis of diabetes.
We provide a strong network of convenient neighborhood hearing care centers across the country that continually strives to find innovative ways to serve you better. Our Hearing Care Professionals are passionate about helping people to hear better, applying a consistent process to determine the best recommendations for your hearing health. We provide free next day evaluations with professional recommendations based upon your inidiviudal hearing needs and lifestyle. We offer a walk-in, walk-out 2-week FREE trial with hearing aids that are right for you - plus the Connect Advantage, your assurance Connect Hearing will be there every step of the way. Headquartered in the Chicago area, we are a fast growing division of Sonova (SOON:US), the world`s leading provider of innovative hearing healthcare solutions.
Mr. Gallagher is Senior Vice President & Chief Financial Officer at RRD International, LLC. Mr. Gallagher provides strategic, operational, and financial leadership to RRD. His primary responsibilities are planning, implementing, managing, and controlling all financial-related activities including the development of financial and operational strategies. Mr. Gallagher has over 20 years of finance experience in the biopharma industry with both multi-national corporations and commercial-stage public biotechnology companies. He has an extensive background in all areas of corporate controllership, including financial planning & analysis, cost control, management accounting, corporate administration, and systems implementation. He has supported all aspects of product development and commercialization, including the negotiation and execution of licensing and collaboration agreements with major pharma partners. Mr. Gallagher served previously as Vice President of Finance for Optimer Pharmaceuticals and, prior to that, as Senior Director of Finance and Corporate Controller for Adolor Corporation. He had a central role in the sale of both companies. Mr. Gallagher spent the first 10 years of his career with Therakos, Inc. (a Johnson & Johnson company) and Merck & Co., Inc. He received his BS in Finance from The Pennsylvania State University and is an active Certified Management Accountant (CMA).